Anti-tumor-promoting activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis HA et GRUSHV. (I)

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 8, 1998, Pages 834-838

  Konoshima, Takao ^a   Takasaki, Midori ^a   Tokuda, Harukuni ^b   Nishino, Hoyoku ^b   Duc, Nguyen Minh ^c   Kasai, Ryoji ^d   Yamasaki, Kazuo ^d  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti tumor promoter; Cell cycle analysis; Fumonisin B1; Majonoside R2; Ocotillol type saponin; Panax vietnamensis

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; EARLY ANTIGEN; FUMONISIN B1; MAJONOSIDE R2; PHORBOL 13 ACETATE 12 MYRISTATE; SAPONIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CELL CYCLE; DRUG ISOLATION; EPSTEIN BARR VIRUS; GINSENG; HUMAN; HUMAN CELL; VIRUS INHIBITION;

EID: 0031756304     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.834     Document Type: Article

References (26)

1. A part of this work was presented at the International Symposium on Natural Medicines, Kyoto, October 1997, Abstracts Papers, p. 168.
2. Bruneton J., Hatton C. K., "Pharmacognosy. Phytochemistry, Medicinal Plants" Lavoisier Publishing, New York, 1995, p 563; Jiangsu New Medical College, ed., "Chinese Materia Medica," Shanghai People's Pub. House, Shanghai, 1997. pp. 1923, 2957, 4126 and 3563.
3. Bruneton J., Hatton C. K., "Pharmacognosy. Phytochemistry, Medicinal Plants" Lavoisier Publishing, New York, 1995, p 563; Jiangsu New Medical College, ed., "Chinese Materia Medica," Shanghai People's Pub. House, Shanghai, 1997. pp. 1923, 2957, 4126 and 3563.
4. Yamamoto N., Bister K., Zur-Hausen H., Nature (London), 278, 553-554 (1979); Verma A. K., Slaga T. J., Wertz P. W., Mueller G. C., Boutwell R. K., Cancer Res., 40, 2367-2371 (1980). and references cited therein.
5. Yamamoto N., Bister K., Zur-Hausen H., Nature (London), 278, 553-554 (1979); Verma A. K., Slaga T. J., Wertz P. W., Mueller G. C., Boutwell R. K., Cancer Res., 40, 2367-2371 (1980). and references cited therein.
6. Konoshima T., Takasaki M., Kozuka M., Nagao T., Okabe H., Irino N., Nakasumi T., Tokuda H., Nishino H., Biol. Pharm. Bull., 18, 284-287 (1995); Konoshima T., Takasaki M., Tokuda H., Masuda K., Arai Y., Shiojima K., Ageta H., ibid., 19, 962-965 (1996).
7. Konoshima T., Takasaki M., Kozuka M., Nagao T., Okabe H., Irino N., Nakasumi T., Tokuda H., Nishino H., Biol. Pharm. Bull., 18, 284-287 (1995); Konoshima T., Takasaki M., Tokuda H., Masuda K., Arai Y., Shiojima K., Ageta H., ibid., 19, 962-965 (1996).
8. Konoshima T., Takasaki M., Kozuka M., Tokuda H., Nishino H., Matsuda E., Nagai M., Biol. Pharm. Bull., 20, 865-868 (1997), and references cited therein.
9. Takasaki M., Konoshima T., Kozuka M., Tokuda H., Biol. Pharm. Bull., 18, 435-438 (1995).
10. Takasaki M., Konoshima T., Yasuda I., Hamano T., Tokuda H., Biol. Pharm. Bull., 20, 776-780 (1997), and references cited therein.
11. Konoshima T., Takasaki M., Tokuda H., Natural Medicines, 50, 158-162 (1996).
12. Duc N. M., Kasai R., Ohtani K., Ito A., Nham N. T., Yamasaki K., Tanaka O., Chem. Pharm. Bull., 42, 634-640 (1994), and references cited therein.
13. Duc N. M., Nham N. T., Kasai R., Ito A., Yamasaki K., Tanaka O., Chem. Pharm. Bull., 41, 2010-2014 (1993).
14. Huong N. T. T., Matsumoto K., Yamasaki K., Duc N. M., Nham N. T., Watanabe H., Pharm. Biochem. Behavior, 53, 957-963 (1996).
15. Tokuda H., Therapeutic Res., 16, 32-34 (1995); Fukuda H., Shima H., Vesonder R. F., Tokuda H., Nishino H., Katoh S., Tamura S., Sugimura T., Nagao M., Biochem. Biophys. Res. Comm., 220, 160-165 (1996).
16. Tokuda H., Therapeutic Res., 16, 32-34 (1995); Fukuda H., Shima H., Vesonder R. F., Tokuda H., Nishino H., Katoh S., Tamura S., Sugimura T., Nagao M., Biochem. Biophys. Res. Comm., 220, 160-165 (1996).
17. Henle G., Henle W., J. Bacteriol., 91, 1248-1256 (1966).
18. Taylor I. W., J. Histochem. Cytochem., 28, 1021-1024 (1980); Shimomatsuya T., Tanigawa N., Muraoka R., Jpn. J. Cancer Res. (Gann), 82, 357-362 (1991).
19. Taylor I. W., J. Histochem. Cytochem., 28, 1021-1024 (1980); Shimomatsuya T., Tanigawa N., Muraoka R., Jpn. J. Cancer Res. (Gann), 82, 357-362 (1991).
20. 8)
21. A high viability of Raji cells is necessary for in vitro asay using an indirect immunofluorescence technique by antigen-antibody reaction and is beneficial for the following in vivo assay.
22. 2 and 1×10 mol ratio/TPA, respectively and the viability percentage of Raji cells was more than 80% at each concentration, Tokuda H., Ohigashi H., Koshimizu K., Ito Y., Cancer Lett., 33, 279-282 (1986); Mizutani K., "Food Phytochemicals for Cancer Chemoprevention II, Teas, Spices, and Herbs," ed. by Ho C.-T. Osawa T., Huang M.-T. Rosen R.T., American Chemical Society, Washinton, D.C., 1994, pp. 322-328.
23. 2 and 1×10 mol ratio/TPA, respectively and the viability percentage of Raji cells was more than 80% at each concentration, Tokuda H., Ohigashi H., Koshimizu K., Ito Y., Cancer Lett., 33, 279-282 (1986); Mizutani K., "Food Phytochemicals for Cancer Chemoprevention II, Teas, Spices, and Herbs," ed. by Ho C.-T. Osawa T., Huang M.-T. Rosen R.T., American Chemical Society, Washinton, D.C., 1994, pp. 322-328.
24. Konoshima T., Kokumai M., Kozuka M., Tokuda H., Nishino H., Iwashima A., J. Nat. Prod., 56, 1776-1778 (1992); Konoshima T., Takasaki M., Tatsumoto T., Kozuka M., Kasai R., Tanaka O., Nie R-L., Tokuda H., Nishino H., Iwashima A., Biol. Pharm. Bull., 17, 668-671 (1994).
25. Konoshima T., Kokumai M., Kozuka M., Tokuda H., Nishino H., Iwashima A., J. Nat. Prod., 56, 1776-1778 (1992); Konoshima T., Takasaki M., Tatsumoto T., Kozuka M., Kasai R., Tanaka O., Nie R-L., Tokuda H., Nishino H., Iwashima A., Biol. Pharm. Bull., 17, 668-671 (1994).
26. Tokuda H., Konoshima T., Nishino H., Abstract of Papers, The 42nd Annual Meeting of Japanese Society of Pharmacognosy, Fukuyama, Japan, September, 1995, p. 184.